Anandamide (N-arachidonoylethanolamine) was the first ligand to be identified as an
endogenous ligand of the G-protein coupled cannabinoid CB1 receptor. Subsequently, two …

Anandamide (N-arachidonoylethanolamine) has been identified as an endogenous ligand
of the G-protein coupled cannabinoid CB1 receptor. Recent studies have postulated the …

The cannabinoid CB1 and CB2 receptors are Class AG protein-coupled receptors (GPCRs).
While many Class A GPCRs have endogenous ligands that are hydrophilic cations (eg, the …

The identification of arachidonylethanolamide (anandamide, AEA) as an endogenous
cannabinoid has been an important development in cannabinoid research which has led to …

Novel aromatic analogues of N-oleoylethanolamine and N-arachidonoylethanolamine
(anandamide, AEA) were synthesized and, based on the capability of similar compounds to …

We reported previously that synthetic amides of polyunsaturated fatty acids with bioactive
amines can result in substances that interact with proteins of the endogenous cannabinoid …

Endocannabinoids are endogenous ligands of the cannabinoid receptors CB 1 and CB 2.
Two arachidonic acid derivatives, arachidonoylethanolamide (anandamide) and 2 …

The cannabinoid field is currently an active research area. Anandamide (AEA) and 2-
arachidonoylglycerol (2-AG) are the most characterized endogenous cannabinoids (also …

N‐arachidonylethanolamide (anandamide or AEA) is an endogenous long‐chain fatty acid
ethanolamide with activity at both the cannabinoid 1 (CB 1) and cannabinoid 2 (CB 2) …

The endocannabinoid anandamide (AEA) has many neurovascular activities. However, it is
not yet clear how AEA can be metabolized at the neurovascular interface, and how it can …